{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T06:53:51Z","timestamp":1781420031636,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.14283\/jpad.2024.49","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T13:43:53Z","timestamp":1709127833000},"page":"1041-1046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-\u03b242 over Amyloid Positron Emission Tomography"],"prefix":"10.1016","volume":"11","author":[{"given":"J.-M.","family":"Pyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SangYun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.14283\/jpad.2024.49_bib1","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2024.49_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.14283\/jpad.2024.49_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","article-title":"Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.14283\/jpad.2024.49_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.14283\/jpad.2024.49_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/alz.12366","article-title":"Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis","volume":"18","author":"J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2024.49_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.14283\/jpad.2024.49_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jalz.2010.03.012","article-title":"Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core","volume":"6","author":"Cairns","year":"2010","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.14283\/jpad.2024.49_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"Shaw","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.14283\/jpad.2024.49_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.14283\/jpad.2024.49_bib12","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2024.49_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav"},{"issue":"4","key":"10.14283\/jpad.2024.49_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","article-title":"A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment","volume":"6","author":"Gibbons","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.14283\/jpad.2024.49_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.783996","article-title":"Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis","volume":"14","author":"Margraf","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.14283\/jpad.2024.49_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad159","article-title":"Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy","volume":"5","author":"Sembill","year":"2023","journal-title":"Brain Commun"},{"issue":"9","key":"10.14283\/jpad.2024.49_bib17","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1212\/WNL.0000000000005030","article-title":"Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta- analysis","volume":"90","author":"Charidimou","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.14283\/jpad.2024.49_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ana.26610","article-title":"Decreased Cerebrospinal Fluid Amyloid \u03b2 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy [published correction appears in Ann Neurol. 2023 Jun 9;:]","volume":"93","author":"De Kort","year":"2023","journal-title":"Ann Neurol"},{"issue":"4","key":"10.14283\/jpad.2024.49_bib19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-191254","article-title":"Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy","volume":"74","author":"Banerjee","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.14283\/jpad.2024.49_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jnnp-2017-316851","article-title":"Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance","volume":"89","author":"Charidimou","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.14283\/jpad.2024.49_bib21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00259-019-04314-7","article-title":"Clinical significance of amyloid \u03b2 positivity in patients with probable cerebral amyloid angiopathy markers","volume":"46","author":"Jang","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.14283\/jpad.2024.49_bib22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/jnnp-2016-314697","article-title":"The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice","volume":"88","author":"Banerjee","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.14283\/jpad.2024.49_bib23","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1161\/STROKEAHA.116.012999","article-title":"Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment","volume":"47","author":"Case","year":"2016","journal-title":"Stroke"},{"issue":"4","key":"10.14283\/jpad.2024.49_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"issue":"6","key":"10.14283\/jpad.2024.49_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:34:24Z","timestamp":1736465664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2274580724000293"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.49","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-\u03b242 over Amyloid Positron Emission Tomography","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.49","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}